You are here

  • Home
  • Archive
  • Volume 32, Issue 12
  • INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS

Citation Tools

Article menu
Download PDFPDF
RCEM 2015 Abstracts
TOP SCORING NON TRAINEES
009
INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pollack C, Eikelboom J, Weitz J, et al
INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS
Emergency Medicine Journal 2015;32:979-980.